CoChat

Feasibility and Preliminary Efficacy of Aerobic Acute Exercise Prior to Immunotherapy and Chemotherapy Infusion in Patients with Metastatic Non-Small Cell Lung Cancer: A Randomized Controlled Trial

Open access

The DOI matches its Crossref record; 33 of the 41 references it cites were found in a registry or an index, and 2 are not checked yet; none of the 18 sources its claims cite is checked for support yet.

Abstract

Background/Objectives: Recent preclinical studies suggest that acute exercise induces immune modulation, enhances tumor blood perfusion, and is associated with reduced tumor growth. Adding exercise to immunochemotherapy treatment (ICT) has been proposed as a strategy to increase treatment effectiveness. The ERICA trial (NCT04676009) aimed to assess the feasibility of acute aerobic exercise performed immediately before the administration of ICT in patients with metastatic non-small cell lung cancer (mNSCLC) and to explore hypothesis-generating outcomes related to physical fitness and patient-reported outcomes. Methods: Newly diagnosed mNSCLC patients were randomly assigned (2:1) to the exercise or control group. The exercise intervention included supervised acute exercise before each of four ICT cycles plus a 3-month home-based walking program with an activity tracker and step goals. The feasibility of the exercise protocol was assessed through adherence, acceptability, tolerability, and safety. Clinical, physical, and patient-reported outcomes were assessed at baseline and after 3 months. Results: Twenty-six patients (mean age 60.6 years; SD 10.65) participated, with an 87.5% acceptance rate. In the exercise group (n = 17), 80.9% of participants completed the acute exercise sessions, with a median interval of 38 min [IQR, 20–60] between exercise and ICT. No exercise-related adverse effects were reported. After 3 months, 60% of participants in the exercise group were classified as active and maintained their step goals. Self-reported measures suggest that maintaining physical fitness is favorable for reducing fatigue and insomnia, and therefore improving quality of life. Conclusions: Acute exercise performed immediately before each ICT administration in patients with mNSCLC appears feasible and safe.

Checked 2026-10-11 · 2 references not checked yet

Overview

CoChat Summary

TL;DR

This randomized feasibility trial tested supervised aerobic exercise immediately before immunotherapy/chemotherapy infusion in patients with metastatic NSCLC and found the intervention was feasible, with high acceptance and no exercise-related adverse events. Preliminary efficacy signals were mixed: some patient-reported outcomes and activity levels improved, but physical fitness and body composition did not.

Key findings

  • Of 91 screened patients, 45 were eligible (49.5%); of the 32 to whom the study was presented, 4 declined, yielding an acceptance rate of 87.5%. The final randomized sample was 26 patients: 17 in the exercise group and 9 in control.
  • Adherence to the acute exercise sessions was 80.8% on average; the median number of completed sessions was 4 [IQR, 3–4], and 52.9% completed all four sessions. The median time from exercise end to ICT start was 38 min [IQR, 20–60].
  • Tolerability was acceptable: exercise dose adjustments were needed for 58.8% of participants, accounting for 48.1% of sessions, and no serious exercise-related adverse events were reported.
  • Preliminary effects were limited: there were no meaningful between-group differences in physical fitness at 3 months, but the exercise group’s global leisure-time physical activity score increased from 13.8 ± 14.5 to 30.9 ± 14.8. In contrast, skeletal muscle index decreased in the exercise group from 49.2 ± 6.16 to 46.2 ± 7.26 cm²/m² (p = 0.02), and control participants experienced more grade 3–4 treatment-emergent adverse events (11 grade 3 and 2 grade 4 vs 3 grade 3 and 1 grade 4 in the exercise group).

Methods

  • Prospective, single-center, 2:1 randomized controlled open-label feasibility study (ERICA) conducted from January 2021 to June 2023 at the Léon Bérard Comprehensive Cancer Centre in Lyon, France.
  • Included adults aged ≥18 and <80 years with metastatic NSCLC without EGFR mutation or ALK rearrangement, eligible for first-line pembrolizumab-based immunochemotherapy, with WHO performance status <2 and no contraindication to exercise.
  • Intervention: supervised acute cycling exercise immediately before each of four ICT cycles, individualized to submaximal fitness, plus a 3-month home walking program targeting ≥6000 steps/day; analyses compared baseline and 3-month outcomes using nonparametric and paired tests.

Limitations

  • The paper states the main limitation was the small sample size, which limited statistical power and generalizability.
  • The authors also state the analyses were exploratory, unadjusted, and at risk of false positives due to multiple outcomes.
  • Evident from the text: single-center design and logistical constraints affected enrollment and implementation, including 6 eligible patients not enrolled because treatment started too soon and 31% of exercise-to-infusion intervals exceeding 60 min.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/jcm15010334

Cites

33 of 41 references verified0 citation errors · 6 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 CONSORT flow diagram of the ERICA randomized controlled trial.
Figure 1 CONSORT flow diagram of the ERICA randomized controlled trial.CC BY · PubMed Central
Figure 2 Evolution of adherence to acute exercise sessions before ICT administration, i.e., completed as scheduled (in blue), modified (duration and/or intensity; in yellow), or not performed (in red). S1, S2, S3 and S4 = acute exercise session before ICT cycles 1, 2, 3 and 4, respectively.
Figure 2 Evolution of adherence to acute exercise sessions before ICT administration, i.e., completed as scheduled (in blue), modified (duration and/or intensity; in yellow), or not performed (in red). S1, S2, S3 and S4 = acute exercise session before ICT cycles 1, 2, 3 and 4, respectively.CC BY · PubMed Central
Figure 3 Boxplots showing the distribution of daily steps per week between treatment cycles in the exercise group. Data are presented as the median (IQR).
Figure 3 Boxplots showing the distribution of daily steps per week between treatment cycles in the exercise group. Data are presented as the median (IQR).CC BY · PubMed Central
Figure 4 Comparison of physical fitness between groups at baseline and M3. Histograms showing changes in oxygen consumption at VT1 (A), isometric quadriceps strength (B) and handgrip strength (C,D) maximum in the exercise and control group. The bars represent the means, and the error lines indicate the standard deviation. M3: Month3.
Figure 4 Comparison of physical fitness between groups at baseline and M3. Histograms showing changes in oxygen consumption at VT1 (A), isometric quadriceps strength (B) and handgrip strength (C,D) maximum in the exercise and control group. The bars represent the means, and the error lines indicate the standard deviation. M3: Month3.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 13 Not checked · 61 Own results and interpretations

27 more claims

Create a free account to see all 74 claims and to verify the 18 references still open.

See all claims — free account
  • It may state two separate claims as one. 35
  • Probably not a substantial claim. 14

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 41 references

Cited by

See all 3

Metadata

Authors
Gouez, M., Pérol, O., Pialoux, V., Avrillon, V., Boussageon, M., Decroisette, C., Delrieu, L., El Hajj, H., Fournier, B., Gille, R., His, M., Mastroianni, B., Swalduz, A., Pérol, M., & Fervers, B.
Affiliations
  • Lyon 1 Université (FR)
  • Inserm (FR)
  • Centre Léon Bérard (FR)
  • Department of Cancer Prevention and Environment, Léon Bérard Cancer Center, 69008 Lyon, France
  • Department of Medical Oncology, Léon Bérard Cancer Center, 69008 Lyon, France
Corresponding author
Gouez, Manon
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2026-01-01
Volume
15
Issue
1
Pages
334
ISSN
2077-0383 (ISSN-L)
OpenAlex
W7117961821
Cited by
3
References
41
Citations by year
2026: 3
FWCI
8.88
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
Funders
French Ministry of Education, Research and Innovation (Doctoral Fellowship)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
Keywords
acute aerobic exercise, metastatic non-small cell lung cancer, immunotherapy, chemotherapy, chemoimmunotherapy, physical fitness, exercise adherence, fatigue, insomnia, quality of life, feasibility and safety

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Feasibility and Preliminary Efficacy of Aerobic Acute Exercise Prior to Immunotherapy and Chemotherapy Infusion in Patients with Metastatic Non-Small Cell Lung Cancer: A Randomized Controlled Trial. https://app.cochat.ai/papers/10.3390/jcm15010334
The paper
Gouez, M., Pérol, O., Pialoux, V., Avrillon, V., Boussageon, M., Decroisette, C., Delrieu, L., El Hajj, H., Fournier, B., Gille, R., His, M., Mastroianni, B., Swalduz, A., Pérol, M., & Fervers, B. (2026). Feasibility and Preliminary Efficacy of Aerobic Acute Exercise Prior to Immunotherapy and Chemotherapy Infusion in Patients with Metastatic Non-Small Cell Lung Cancer: A Randomized Controlled Trial. Journal of Clinical Medicine. https://doi.org/10.3390/jcm15010334

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.